250 related articles for article (PubMed ID: 15836619)
1. Regulation of glutamate carboxypeptidase II hydrolysis of N-acetylaspartylglutamate (NAAG) in crayfish nervous tissue is mediated by glial glutamate and acetylcholine receptors.
Urazaev AK; Grossfeld RM; Lieberman EM
J Neurochem; 2005 May; 93(3):605-10. PubMed ID: 15836619
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms for clearance of released N-acetylaspartylglutamate in crayfish nerve fibers: implications for axon-glia signaling.
Urazaev AK; Buttram JG; Deen JP; Gafurov BS; Slusher BS; Grossfeld RM; Lieberman EM
Neuroscience; 2001; 107(4):697-703. PubMed ID: 11720792
[TBL] [Abstract][Full Text] [Related]
3. N-acetylaspartylglutamate (NAAG) is the probable mediator of axon-to-glia signaling in the crayfish medial giant nerve fiber.
Gafurov B; Urazaev AK; Grossfeld RM; Lieberman EM
Neuroscience; 2001; 106(1):227-35. PubMed ID: 11564432
[TBL] [Abstract][Full Text] [Related]
4. Glutamate carboxypeptidase II (GCPII) inhibitor 2-PMPA reduces rewarding effects of the synthetic cathinone MDPV in rats: a role for N-acetylaspartylglutamate (NAAG).
Hicks C; Gregg RA; Nayak SU; Cannella LA; Schena GJ; Tallarida CS; Reitz AB; Smith GR; Rawls SM
Psychopharmacology (Berl); 2017 Jun; 234(11):1671-1681. PubMed ID: 28251297
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and release of N-acetylaspartylglutamate (NAAG) by crayfish nerve fibers: implications for axon-glia signaling.
Urazaev AK; Grossfeld RM; Fletcher PL; Speno H; Gafurov BS; Buttram JG; Lieberman EM
Neuroscience; 2001; 106(1):237-47. PubMed ID: 11564433
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotection afforded by NAAG and NAALADase inhibition requires glial cells and metabotropic glutamate receptor activation.
Thomas AG; Olkowski JL; Slusher BS
Eur J Pharmacol; 2001 Aug; 426(1-2):35-8. PubMed ID: 11525768
[TBL] [Abstract][Full Text] [Related]
7. Deletion of the glutamate carboxypeptidase II gene in mice reveals a second enzyme activity that hydrolyzes N-acetylaspartylglutamate.
Bacich DJ; Ramadan E; O'Keefe DS; Bukhari N; Wegorzewska I; Ojeifo O; Olszewski R; Wrenn CC; Bzdega T; Wroblewska B; Heston WD; Neale JH
J Neurochem; 2002 Oct; 83(1):20-9. PubMed ID: 12358725
[TBL] [Abstract][Full Text] [Related]
8. [Synthesis and release of N-acetylaspartyl glutamate (NAAG) in medial giant axons in crayfish].
Urazaev AKh; Gafurov BSh; Grossfeld RM; Fletcher PL; Lieberman EM
Ross Fiziol Zh Im I M Sechenova; 2001 Apr; 87(4):476-91. PubMed ID: 11449975
[TBL] [Abstract][Full Text] [Related]
9. Still NAAG'ing After All These Years: The Continuing Pursuit of GCPII Inhibitors.
Vornov JJ; Hollinger KR; Jackson PF; Wozniak KM; Farah MH; Majer P; Rais R; Slusher BS
Adv Pharmacol; 2016; 76():215-55. PubMed ID: 27288079
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of NMDA receptor contribution to axon-to-glia signaling in the crayfish medial giant nerve fiber.
Gafurov BS; Urazaev AK; Grossfeld RM; Lieberman EM
Glia; 2002 Apr; 38(1):80-6. PubMed ID: 11921205
[TBL] [Abstract][Full Text] [Related]
11. NAAG Peptidase Inhibitors Act via mGluR3: Animal Models of Memory, Alzheimer's, and Ethanol Intoxication.
Olszewski RT; Janczura KJ; Bzdega T; Der EK; Venzor F; O'Rourke B; Hark TJ; Craddock KE; Balasubramanian S; Moussa C; Neale JH
Neurochem Res; 2017 Sep; 42(9):2646-2657. PubMed ID: 28285415
[TBL] [Abstract][Full Text] [Related]
12. Molecular modeling of the interactions of glutamate carboxypeptidase II with its potent NAAG-based inhibitors.
Rong SB; Zhang J; Neale JH; Wroblewski JT; Wang S; Kozikowski AP
J Med Chem; 2002 Sep; 45(19):4140-52. PubMed ID: 12213057
[TBL] [Abstract][Full Text] [Related]
13. Effect of N-acetylaspartylglutamate (NAAG) on non-quantal and spontaneous quantal release of acetylcholine at the neuromuscular synapse of rat.
Malomouzh AI; Nikolsky EE; Lieberman EM; Sherman JA; Lubischer JL; Grossfeld RM; Urazaev AKh
J Neurochem; 2005 Jul; 94(1):257-67. PubMed ID: 15953368
[TBL] [Abstract][Full Text] [Related]
14. Protection against glucose-induced neuronal death by NAAG and GCP II inhibition is regulated by mGluR3.
Berent-Spillson A; Robinson AM; Golovoy D; Slusher B; Rojas C; Russell JW
J Neurochem; 2004 Apr; 89(1):90-9. PubMed ID: 15030392
[TBL] [Abstract][Full Text] [Related]
15. A role for the locus coeruleus in the analgesic efficacy of N-acetylaspartylglutamate peptidase (GCPII) inhibitors ZJ43 and 2-PMPA.
Nonaka T; Yamada T; Ishimura T; Zuo D; Moffett JR; Neale JH; Yamamoto T
Mol Pain; 2017 Jan; 13():1744806917697008. PubMed ID: 28326936
[TBL] [Abstract][Full Text] [Related]
16. N-acetylaspartylglutamate activates cyclic AMP-coupled metabotropic glutamate receptors in cerebellar astrocytes.
Wroblewska B; Santi MR; Neale JH
Glia; 1998 Oct; 24(2):172-9. PubMed ID: 9728763
[TBL] [Abstract][Full Text] [Related]
17. NAAG peptidase inhibitors block cognitive deficit induced by MK-801 and motor activation induced by d-amphetamine in animal models of schizophrenia.
Olszewski RT; Janczura KJ; Ball SR; Madore JC; Lavin KM; Lee JC; Lee MJ; Der EK; Hark TJ; Farago PR; Profaci CP; Bzdega T; Neale JH
Transl Psychiatry; 2012 Jul; 2(7):e145. PubMed ID: 22850437
[TBL] [Abstract][Full Text] [Related]
18. S1 pocket of glutamate carboxypeptidase II: a new binding site for amyloid-β degradation.
Lee SK; Kim H; Cheong YH; Kim MJ; Jo SA; Youn HS; Park SI
Biochem Biophys Res Commun; 2013 Sep; 438(4):765-71. PubMed ID: 23891752
[TBL] [Abstract][Full Text] [Related]
19. Kinetics and inhibition of glutamate carboxypeptidase II using a microplate assay.
Rojas C; Frazier ST; Flanary J; Slusher BS
Anal Biochem; 2002 Nov; 310(1):50-4. PubMed ID: 12413472
[TBL] [Abstract][Full Text] [Related]
20. Effects of N-acetylaspartylglutamate (NAAG) at group II mGluRs and NMDAR.
Fricker AC; Mok MH; de la Flor R; Shah AJ; Woolley M; Dawson LA; Kew JN
Neuropharmacology; 2009; 56(6-7):1060-7. PubMed ID: 19285517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
